openPR Logo
Press release

Combination Antibody Therapy Market is Projected to Witness a Staggering Growth During 2016-2024

10-13-2017 07:57 AM CET | Health & Medicine

Press release from: Persistence Market Research

Combination Antibody Therapy Market is Projected to Witness

Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination antibody drugs are actively focusing on developing superior drugs that will deliver standout results. Factors such as encouraging government policies, growing concerns over higher cancer prevalence worldwide, and increasing research and development activities coupled with heavier investments are expected to boost the overall market growth in the near future. Likewise, healthy R&D pipelines are leading towards higher product offerings and also propelling the growth of global combination antibody therapy market to a significant extent.

Higher success ratio in treating and preventing cancer cells using combination antibody therapy is fuelling the demand for combination antibody drugs in the market. A study conducted by Persistence Market Research (PMR) shows that the global market for combination antibody therapy is set to ride on a value CAGR of over 14% during the period of assessment to reach US$ 144,734.5 Million by 2024 end. In 2016, the global market was valued at over US$ 49,994 Million characterizing the overwhelming popularity of antibody/antibody drugs amongst both practitioners and patients observed in recent years.

The prolonged attrition rate in product development cycle and arbitrary and stringent drug approval procedures are the major downsides of the market that are likely to inhibit the market growth during the forecast period. Moreover, lack of awareness on understanding the difference between immunotherapies and chemotherapies amongst healthcare professionals, which is restricting the optimal use of immunotherapies alongside conventional treatment modalities is an additional factor impeding the market growth. Further, late diagnosis or ignorance of any carcinogenic disorders may inevitably lead to higher cost of treatment.

Based on combinations, antibody/antibody is projected to be the predominant segment of the market over the forecast period. In terms of revenue, the segment is expected to witness a healthy CAGR of over 17% between 2016 and 2024. The growth is attributed to the increasing preference of antibody/antibody drugs as they have a lower risk of side effects for various cancer therapies. Whereas, the chemotherapy/antibody segment will hold the second position, accounting for 38.3% share of the market in 2016.

View and Download TOC of Combination Antibody Therapy Market Research Report@ https://www.persistencemarketresearch.com/market-research/combination-antibody-therapy-market/toc

Demand for combination antibody therapy will be high for breast cancer and lung cancer treatment on the basis of applications. The lung cancer segment is anticipated to expand at a value CAGR of 17.1% during the assessment period.

By end user, hospitals are expected to be the largest segment of the market throughout the forecast period. In 2015, the segment was valued at US$ 26,906.5 Million, which is expected to surpass US$ 95,885 Million by 2024 end, reflecting a CAGR of 15.2%.

Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/11740

From a regional perspective, North America will continue to be the leading market for combination antibody therapy over the forecast period. In addition, the region is set to witness a CAGR of over 13% in terms of value. Whereas, APAC is expected to reflect the fastest growth of the market during the forecast period in terms of value. Further, the market in the region is estimated to witness a 3.4X growth in terms of sales over 2024 owing to increasing prevalence of carcinogenic disorders in APAC.

Key participants functioning in the global market for combination antibody therapy include Roche Holdings AG, Amgen Incorporated, Novartis AG, Celgene Corporation, Biogen Inc., Seattle Genetics Inc., Genmab A/S, Bristol-Myers Squibb Company, Eli-Lilliy and Company and Sanofi.

Buy Full Combination Antibody Therapy Market Report@ https://www.persistencemarketresearch.com/checkout/11740

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Combination Antibody Therapy Market is Projected to Witness a Staggering Growth During 2016-2024 here

News-ID: 771575 • Views:

More Releases from Persistence Market Research

Computer Numerical Control (CNC) Machines Market Forecast, Technological Advancements Fueling Industrial Transformation
Computer Numerical Control (CNC) Machines Market Forecast, Technological Advance …
Market Overview The global Computer Numerical Control (CNC) machines market is witnessing robust growth as industries increasingly adopt advanced manufacturing technologies to boost precision, speed, and productivity. In 2023, the market was valued at US$6.2 billion and is forecast to expand at a CAGR of 9.5%, reaching US$11.7 billion by 2030. CNC machines, which automate control of machining tools through computer programming, have become an indispensable part of sectors such as
Millimeter Wave Body Scanner Market to Witness Strong Demand Across Airports & Public Venues
Millimeter Wave Body Scanner Market to Witness Strong Demand Across Airports & P …
Market Overview The millimeter wave body scanner market has emerged as a critical segment within global security technologies, particularly in high-risk environments such as airports, government buildings, and public event venues. These scanners utilize non-ionizing millimeter wave technology to detect concealed objects on a person's body without physical contact, delivering both enhanced accuracy and safety compared to older technologies like X-ray scanners. The increasing need for advanced threat detection systems, coupled
Industrial Cooling System Market, Driving Efficiency and Reliability in Next-Gen Industries
Industrial Cooling System Market, Driving Efficiency and Reliability in Next-Gen …
Market Overview The global industrial cooling system market is witnessing steady growth, driven by rising demand for energy-efficient solutions and expanding applications across industries such as manufacturing, oil & gas, chemicals, power generation, and data centers. Cooling systems are indispensable for maintaining operational efficiency, protecting sensitive machinery, and ensuring workforce safety in environments with extreme heat generation. According to recent projections, the market is expected to expand at a CAGR of
Industrial Automation and Control System Market Insights, Innovations, Segments, and Regional Demand
Industrial Automation and Control System Market Insights, Innovations, Segments, …
Market Overview The global industrial automation and control system market is experiencing rapid transformation as industries embrace digital technologies to boost productivity, reduce costs, and enhance operational efficiency. Valued at US$165.1 Bn in 2023, the market is projected to reach US$307.7 Bn by 2030, expanding at a strong CAGR of 9.3% during the forecast period. The increasing integration of advanced technologies such as artificial intelligence (AI), Internet of Things (IoT), robotics,

All 5 Releases


More Releases for Combination

Advancements in Cancer Combination Therapy
Cancer combination therapy, which involves the use of multiple therapeutic agents, has revolutionized cancer treatment in recent years. This approach leverages the strengths of different therapies to enhance efficacy, reduce toxicity, and overcome drug resistance, leading to better patient outcomes.The concept of combination therapy is not new. It has been used successfully in treating infectious diseases and some chronic conditions. However, its application in cancer therapy has seen significant advancements
Combination Vaccines Market Green and Efficient: The Future of Immunization with …
Combination Vaccines Market to reach over USD 10.11 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Combination Vaccines Market Size, Share & Trends Analysis Report By Technology (Conjugate, Live, Inactivated), Age Group (Pediatric, Adult), Application (Diphtheria, Tetanus, & Pertussis (DTP), Polio, Hepatitis B, Influenza), End-use (Hospitals, Clinics), Region, Market Outlook And Industry Analysis
Combination of light and shade
Designer awning for glass canopies mesmerises with fantastic accentuated lighting Underglass awnings are perfect for patio roofs and conservatories. Because under a glass canopy, they have plenty of protection. One new model is the "markilux 679". It has clean lines in its design, provides plenty of shade and creates a beautiful interplay of light on the patio with its LED lights. Unlike above-glass awnings, underglass awnings are fixed under a glass canopy.
Combination of light and shade
Underglass awning by markilux combines clean design with effective LED technology The "markilux 679" is a new form of solar protection for patio roofs and conservatories. The awning has a modern cubic shape, offers plenty of shade and, with LED Lines controlled by an app, ensures an attractive interplay of light on both the cover and façade of the house. Underglass awnings are perfect for both patio roofs and conservatories. The cover,
Combination Hypertension Agents Market - Maximum Impact on Blood Pressure: Combi …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Combination Hypertension Agents Market. Combination Hypertension Agents Market: https://www.growthplusreports.com/report/combination-hypertension-agents-market/9169 The Combination Hypertension Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Fixed-Dose Combination Drugs Market - Leading Innovation in Combination Drug Del …
Newark, New Castle, USA - new report, titled Fixed-Dose Combination Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fixed-Dose Combination Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fixed-Dose Combination Drugs market. The report offers an overview of